Cargando…

Medical resource utilization for administration of trastuzumab in a New Zealand oncology outpatient setting: a time and motion study

BACKGROUND: In New Zealand, trastuzumab is standard therapy for human epidermal growth factor receptor-2 (HER2)-positive early and metastatic breast cancer. Given the requirement for ongoing adjuvant or maintenance treatment and intravenous (IV) delivery, such a regimen consumes considerable health...

Descripción completa

Detalles Bibliográficos
Autores principales:	North, Richard T, Harvey, Vernon J, Cox, Levonne C, Ryan, Stuart N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4524269/ https://www.ncbi.nlm.nih.gov/pubmed/26251623 http://dx.doi.org/10.2147/CEOR.S85599

Ejemplares similares

Healthcare resource utilization of patients with mitochondrial disease in an outpatient hospital setting
por: Haque, Sameen, et al.
Publicado: (2023)

Is the Fixed-Dose Intravenous Trastuzumab Policy Warranted in Limited-Resource Settings?
por: Kassem, Loay, et al.
Publicado: (2019)

Clinical oncology in resource-limited settings
por: Buonaguro, Franco M, et al.
Publicado: (2013)

Trastuzumab administration during pregnancy: an update
por: Andrikopoulou, Angeliki, et al.
Publicado: (2021)

Experience With Pre-Dialysis Administration of Tobramycin in the Outpatient Setting
por: Tessier, Jean-François, et al.
Publicado: (2022)

Correction to: Trastuzumab administration during pregnancy: an update
por: Andrikopoulou, Angeliki, et al.
Publicado: (2021)

Resource utilization and cost saving analysis of subcutaneous versus intravenous trastuzumab in early breast cancer patients
por: Farolfi, Alberto, et al.
Publicado: (2017)

Communication skills utilized by physicians in the pediatric outpatient setting
por: Lee, T., et al.
Publicado: (2022)

Survey of infection control resources and services in outpatient settings in China
por: Qiao, F, et al.
Publicado: (2015)

Psychiatric pharmacogenomics predicts health resource utilization of outpatients with anxiety and depression
por: Winner, J, et al.
Publicado: (2013)

A Systematic Review of Time and Resource Use Costs of Subcutaneous Versus Intravenous Administration of Oncology Biologics in a Hospital Setting
por: McCloskey, Conor, et al.
Publicado: (2022)

Enhancing communication in oncology outpatient consultations: critical reflections from doctors
por: Furber, Lynn, et al.
Publicado: (2011)

Sex differences in patterns of referral and resource utilization in the cardiology clinic: an outpatient analysis
por: Vicent, Lourdes, et al.
Publicado: (2023)

The arrival of biosimilar monoclonal antibodies in oncology: clinical studies for trastuzumab biosimilars
por: Barbier, Liese, et al.
Publicado: (2019)

Safety and efficacy of trabectedin when administered in the inpatient versus outpatient setting: Clinical considerations for outpatient administration of trabectedin
por: Jones, Robin L., et al.
Publicado: (2019)

Quality of care in the course of subcutaneous versus intravenous trastuzumab administration in patients with breast cancer: an integrated time–motion study with mixed-methods research
por: Lin, Hsiang-Wen, et al.
Publicado: (2023)

The impact of a supplementary medication review and counselling service within the oncology outpatient setting
por: Read, H, et al.
Publicado: (2007)

The Patient–Healthcare Professional Relationship and Communication in the Oncology Outpatient Setting: A Systematic Review
por: Prip, Anne, et al.
Publicado: (2018)

Implementing a 3As and ‘Opt-Out’ Tobacco Cessation Framework in an Outpatient Oncology Setting
por: Himelfarb-Blyth, Sarah, et al.
Publicado: (2021)

Room for improvement in capturing cancer family history in a gynecologic oncology outpatient setting
por: Lin, Jenny, et al.
Publicado: (2022)

Symptoms associated with healthcare resource utilization in the setting of inflammatory bowel disease
por: Bogale, Kaleb, et al.
Publicado: (2022)

Hospital-based or home-based administration of oncology drugs? A micro-costing study comparing healthcare and societal costs of hospital-based and home-based subcutaneous administration of trastuzumab
por: Franken, Margreet, et al.
Publicado: (2020)

Real‐world dosing characteristics and utilization of parenteral treprostinil in the outpatient setting
por: Balasubramanian, Vijay P., et al.
Publicado: (2022)

The landscape of digital resources in radiation oncology
por: Culbert, Matthew M., et al.
Publicado: (2022)

Prospective Analysis of Radiology Resource Utilization and Outcomes for Participation in Oncology Multidisciplinary Conferences
por: Shenoy-Bhangle, Anuradha S, et al.
Publicado: (2020)

PENS approach for breaking bad news in the oncology outpatient setting: a real-world report
por: Mailankody, Sharada, et al.
Publicado: (2022)

Prices of oncology medicines in European countries, Australia and New Zealand
por: Vogler, Sabine, et al.
Publicado: (2015)

Mixed depression and suicidality in oncology outpatients
por: Bernardi, E., et al.
Publicado: (2023)

Subcutaneous administration of rituximab (MabThera) and trastuzumab (Herceptin) using hyaluronidase
por: Shpilberg, O, et al.
Publicado: (2013)

Overcoming Barriers to Radiation Oncology Access in Low-Resource Settings in the United States
por: Mattes, Malcolm D., et al.
Publicado: (2021)

Cost effectiveness of using trastuzumab biosimilars compared to trastuzumab original drugs to treat breast cancer in a hospital setting
por: Barat, Eric C., et al.
Publicado: (2023)

Trastuzumab in the adjuvant setting: concurrent or sequential? It takes two to tango!
por: Verma, Sunil
Publicado: (2008)

Innovations in Pediatric Drug Formulations and Administration Technologies for Low Resource Settings
por: Gerrard, Stephen E., et al.
Publicado: (2019)

New Zealand National Audit of Outpatient Inflammatory Bowel Disease Standards of Care
por: Hackett, Robert, et al.
Publicado: (2020)

Malignant Melanoma in Children and Adolescents Treated in Pediatric Oncology Centers: An Australian and New Zealand Children’s Oncology Group (ANZCHOG) Study
por: Ryan, Anne L., et al.
Publicado: (2021)

Using national data to model the New Zealand radiation oncology workforce
por: Dunn, Alex, et al.
Publicado: (2022)

Time spent by hospital personnel on drug changes: A time and motion study from an in-and outpatient hospital setting
por: Poulsen, Joo Hanne, et al.
Publicado: (2021)

Utilization of NGS technologies to investigate transcriptomic and epigenomic mechanisms in trastuzumab resistance
por: Nava, Miguel, et al.
Publicado: (2019)

An Evaluation of US Food and Drug Administration’s Program to Register HIV Drugs for Use in Resource-Constrained Settings
por: Chahal, Harinder Singh, et al.
Publicado: (2019)

The Impact of an Embedded Oncology Pharmacist in an Outpatient Oncology Center in the Treatment of Hematologic Malignancies
por: Mae Trinidad, Denisse, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d6gqe01l8soddms8n8goqff8na